Pharma Journalist -

Kinarus Therapeutics Holding AG, a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, announced publication in…
Read More...

The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high…
Read More...

Waters Corporation announced a collaboration with BioInfra, a pioneering contract research organization (CRO) company for the pharmaceutical and clinical fields, to jointly establish…
Read More...

Sandoz, a global leader in generic and biosimilar medicines, announced that the European Medicines Agency (EMA) has accepted the application for high concentration formulation 100 mg/mL…
Read More...

Zura Bio Limited (“Zura Bio”), a clinical-stage biotechnology company focused on developing novel medicines for immune disorders, and JATT Acquisition Corp., a publicly traded special…
Read More...

Hansa Biopharma, "Hansa" announces the recommendation by the National Institute for Health and Care Excellence (NICE) for its first-in-class treatment Idefirix in the desensitization of…
Read More...

Exelixis, Inc. and BioInvent International AB announced that the companies have entered into an option and license agreement focused on the identification and development of novel…
Read More...

Panbela Therapeutics, Inc. a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, announced the closing of its acquisition of Cancer…
Read More...

Humanigen, Inc. announced it entered into an agreement with PCI Pharma Services (PCI), a leading integrated global contract development manufacturing organization (CDMO), to provide…
Read More...

Jazz Pharmaceuticals and Redx announce the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for JZP815, a pan-RAF inhibitor for the…
Read More...